Long intergenic non-protein coding RNA 2693 (LINC02693)

Long intergenic non-protein coding RNA 2693 (LINC02693) is a human long non-coding RNA belonging to the class of long intergenic non-coding RNAs (lincRNAs)[1][2]. These lncRNAs are transcribed but not translated into protein, and often act as regulators of gene expression through a range of mechanisms including chromatin remodeling, RNA-protein interactions, and modulation of transcription or RNA stability[5]. LINC02693 has been identified as differentially expressed in human disease contexts such as type 2 diabetes with cardiovascular complications[2]. It may interact with the E3 ubiquitin ligase TRIM25, which is involved in immune responses, suggesting a regulatory role; however, its precise biological and molecular functions remain largely uncharacterized, and it is not established as a therapeutic target or recognized biomarker[2]. No drugs are known to target LINC02693, and it does not encode a protein product, nor does it fit into classic categories such as receptors, enzymes, or ion channels.

Other names

Putative uncharacterized protein LINC02693C17orf51FLJ12977FLJ31874FLJ33618

Not established. No data on drug targeting or explicit mechanism; general lncRNA mechanisms include acting as molecular scaffolds, guides, decoys, or recruiters of chromatin modifiers in transcriptional regulation.